Butodesnitazene

Last updated

Butodesnitazene
Butodesnitazene structure.png
Identifiers
  • 2-[(4-Butoxyphenyl)methyl]-1-(2-diethylaminoethyl)benzimidazole
Chemical and physical data
Formula C24H33N3O
Molar mass 379.548 g·mol−1
3D model (JSmol)
  • CCN(CC)CCn1c(nc2ccccc12)Cc1ccc(OCCCC)cc1
  • InChI=InChI=1S/C24H33N3O/c1-4-7-18-28-21-14-12-20(13-15-21)19-24-25-22-10-8-9-11-23(22)27(24)17-16-26(5-2)6-3/h8-15H,4-7,16-19H2,1-3H3
  • Key:NOCZAWHIDDFBFO-UHFFFAOYSA-N

Butodesnitazene is a benzimidazole derivative with opioid effects, which has been sold as a designer drug. It was identified by drug checking services in New Zealand in 2025, having been sold on the black market misrepresented as heroin. Its pharmacological properties have not been studied, although based on the known structure-activity relationships of the benzimidazole opioids, it is expected to have comparatively low potency. [1]

See also

References

  1. ↑ Mayer A, Montgomery N, Hughes E, Birks Ang B, Johnson OE (February 2026). "Detection and characterisation of a new nitazene analogue, butodesnitazene: A collaborative approach to the identification of novel psychoactive substances through Drug Checking". Forensic Science International. 378 112717. doi:10.1016/j.forsciint.2025.112717. PMID   41240498.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.